Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE to say no to Tarceva

November 17, 2006
Sales and Marketing NICE, Tarceva

Roche's new lung cancer treatment Tarceva looks set to be refused recommendation from NICE.Tarceva (erlotinib) is the first next-generation treatment …

News

Future global R&D for Bayer Schering defined

November 17, 2006
Research and Development

Following the merger deal between German pharma companies Bayer and Schering earlier this year, the new corporation has unveiled radical …

News

Sanofi-Aventis to expand diabetes and thrombosis work with Euro RSCG

November 17, 2006
Medical Communications

Sanofi-Aventis has retained the agency Euro RSCG Life to promote two of its major brands around the world, insulin analogue …

News

NICE to face judicial review over Alzheimer’s drug decision

November 17, 2006

Legal action is to be taken against NICE over its decision to withdraw approval for NHS drugs for mild and …

News

Surprise delay for Novartis’ Galvus

November 15, 2006
Sales and Marketing Galvus, diabetes

The FDA will take three months longer than expected to review Novartis' new diabetes treatment, Galvus, after the pharma company …

News

Trained to win

November 13, 2006
Business Services, Sales and Marketing marketing, sales, training

Pharmaceutical sales and marketing managers have a dizzying array of training courses, educational aids and events at their disposal, all …

Feature

Genentech to buy biotech Tanox for $900 million

November 10, 2006
Sales and Marketing Genentech

 Genentech is to pay $919 million for Tanox, a biotech company which specialises in monoclonal antibodies.Genentech has been working with …

News

iPod-ready patient information leaflets coming soon

November 10, 2006
Sales and Marketing patients

From next month, patients will be able to learn about their medicines by listening to an iPod, MP3 player or …

News

Roche sponsor early breast cancer leaflet

November 10, 2006
Medical Communications

Roche is backing a new leaflet designed to help patients with newly diagnosed early breast cancer make sense of the …

News

US Democrats to target pharmaceutical prices

November 10, 2006
Sales and Marketing

 The decisive victory of the Democrat party in the US mid-term elections looks set to bring new pressure on pharmaceutical …

News

UK biotech comes to market

November 10, 2006
Research and Development biotech, investment

At last, the signals are getting stronger that the biotechnology industry is poised and ready to tackle the publicly quoted …

Feature

Sepsis drug put back at least two years

November 9, 2006
Research and Development

 AstraZeneca is being forced to conduct a second phase II trial on its sepsis drug, CytoFab.This follows discussions with US, …

News

‘Pulsed’ vitamin D drug could transform advanced prostate cancer treatment

November 9, 2006
Research and Development

American biotech company Novacea says it could be on the brink of revolutionising the prostate cancer market if phase III …

News

Abbott buys cholesterol drug specialists Kos

November 9, 2006
Sales and Marketing

Abbott is to pay $3.7 billion for Kos, the specialist US pharma company which has developed a number of major …

News

Novartis to be first pharma to conduct R&D in China

November 7, 2006
Research and Development Asia, China, Novartis, em

Novartis is to open a major, new pharmaceutical research and development centre in China, becoming the first company in the …

News

Once-a-day colitis drug could take on the leaders

November 7, 2006
Sales and Marketing

Shire is hoping its new, one-a-day treatment approach for ulcerative colitis (UC) will give the market leaders a run for …

News

First class relationships

November 6, 2006
Medical Communications, Sales and Marketing industry relations, key opinion leaders, pharma

Pharma goes 'no frillls'Provocative headlines drawing attention to inappropriate behaviour and misconduct in the medical and pharmaceutical professions have been …

Feature

New drive to cut millions from branded sales on NHS

November 3, 2006
Sales and Marketing generics

Some of the UK's top selling medicines are to be targeted in a new NHS drive to cut millions from …

News

New clinical trials agreement to improve UK research

November 3, 2006
Research and Development

The Department of Health has revised its routine contract for industry-funded NHS clinical trials as a way of improving their …

News

Teva and Schering-Plough UK to collaborate on bowel drug

November 3, 2006
Sales and Marketing

Teva has signed a deal with Schering-Plough UK to co-promote its ulcerative colitis and Crohn's disease treatment, Mesren.Teva hopes that …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026